换一批The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence.
第一作者：
James,Lomas
第一单位：
Centre for Health Economics (CHE), University of York, York, YO10 5DD, UK. james.lomas@york.ac.uk.
作者：
医学主题词
成年人(Adult);抗抑郁药(Antidepressive Agents);费用效益分析(Cost-Benefit Analysis);抑郁症, 更年期(Depressive Disorder, Major);人类(Humans);模型, 经济学(Models, Economic);哌嗪类(Piperazines);质量校正寿命(Quality-Adjusted Life Years);随机对照试验(主题)(Randomized Controlled Trials as Topic);硫化物(Sulfides);技术评估, 生物医学(Technology Assessment, Biomedical)
DOI
10.1007/s40273-016-0417-9
PMID
27289476
发布时间
2022-12-07
- 浏览15
PharmacoEconomics
901-12页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
